Private company

Zosano Pharma Corp

American pharmaceutical preparations company based in Fremont, no longer active.

Last updated Oct 18, 2026.

Overview

IndustryPharmaceutical Preparations
HeadquartersFremont, United States
Incorporated inDE²
Business address34790 Ardentech Court, Fremont, Ca 94555²
Filer categoryNon-accelerated filer, Smaller reporting company²

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

-4016.8%Operating margin³

-3812.1%Net margin³

250.4%Revenue growth, 2021³

-90.8%Return on equity³

0.00×Debt to equity³

-$33.0MFree cash flow³

Where the money goes

Where each dollar of revenue went, fiscal 2021

Research and development

Cost of revenue4¢$796.0K
Research and development96¢$21.0M
Interest1¢$189.0K

Out of $785.0K in revenue.³ The company lost money this year.

Financial statements

Revenue⁴⁵⁶⁷⁸³$785.0K in 2021+151% since 2015

Operating income⁴⁵⁶⁷⁸³-$31.5M in 2021+20% since 2015

Net income⁴⁵⁶⁷⁸³-$29.9M in 2021+5% since 2015

Fiscal year	2015	2016	2017	2018	2019	2020	2021
Revenue	$313.0K⁴	$0⁵	$0⁶	$0⁷	$0⁸	$224.0K³	$785.0K³
Cost of revenue					$0⁸	$171.0K³	$796.0K³
Research and development	$20.4M⁴	$20.5M⁵	$20.1M⁶	$25.5M⁷	$25.4M⁸	$21.6M³	$21.0M³
Operating income	-$26.4M⁴	-$28.6M⁵	-$28.4M⁶	-$35.4M⁷	-$37.2M⁸	-$32.8M³	-$31.5M³
Interest			$817.0K⁶	$379.0K⁷	$523.0K⁸	$719.0K³	$189.0K³
Income tax	$0⁴	$0⁵	$0⁶	$0⁷	$0⁸	$0³	$0³
Net income	-$28.4M⁴	-$29.8M⁵	-$29.1M⁶	-$35.4M⁷	-$37.6M⁸	-$33.4M³	-$29.9M³
Earnings per share						-$0.49³	-$0.27³
Earnings per share (diluted)						-$0.49³	-$0.27³

Total assets⁴⁵⁶⁷⁸³$48.4M in 2021+7% since 2015

Total liabilities⁴⁵⁶⁷⁸³$15.4M in 2021−18% since 2015

Shareholders’ equity⁵⁶⁷⁸³$33.0M in 2021+24% since 2015

Cash⁵⁶⁷⁸³$11.0M in 2021+66% since 2015

Long-term debt⁴⁵⁸³$0 in 2021

Fiscal year	2015	2016	2017	2018	2019	2020	2021
Cash	$6.6M⁵	$15.0M⁵	$11.7M⁶	$9.1M⁷	$6.3M⁸	$35.3M³	$11.0M³
Current assets	$37.3M⁴	$15.3M⁵	$13.4M⁶	$23.4M⁷	$6.8M⁸	$35.7M³	$11.6M³
Total assets	$45.3M⁴	$20.9M⁵	$18.0M⁶	$35.8M⁷	$37.7M⁸	$72.0M³	$48.4M³
Current liabilities	$6.9M⁴	$9.8M⁵	$10.5M⁶	$11.3M⁷	$16.2M⁸	$14.5M³	$11.1M³
Long-term debt	$15.3M⁴	$12.5M⁵	$6.7M⁵		$0⁸	$812.0K³	$0³
Total liabilities	$18.8M⁴	$16.4M⁵	$11.0M⁶	$17.1M⁷	$28.3M⁸	$24.5M³	$15.4M³
Shareholders’ equity	$26.5M⁵	$4.5M⁶	$7.0M⁷	$18.7M⁸	$9.4M³	$47.5M³	$33.0M³
Shares outstanding	12.0M shares⁴	840.8K shares⁵	2.0M shares⁶	12.0M shares⁷	23.5M shares⁸	102.1M shares³	120.2M shares³

Cash from operations⁷⁸³-$27.6M in 2021−5% since 2018

Capital spending⁴⁶⁷⁸³$5.4M in 2021+1155% since 2015

Free cash flow⁷⁸³-$33.0M in 2021−5% since 2018

Fiscal year	2015	2016	2017	2018	2019	2020	2021
Cash from operations				-$29.1M⁷	-$34.8M⁸	-$31.7M³	-$27.6M³
Capital spending	$432.0K⁴	$287.0K⁴	$1.2M⁶	$5.5M⁷	$11.8M⁸	$8.5M³	$5.4M³
Free cash flow				-$34.6M	-$46.6M	-$40.2M	-$33.0M
Dividend per share	$0.00¹⁰	$0.00⁴

Compare Zosano Pharma Corp with another company

Leadership

Who has led Zosano Pharma Corp, and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Chief financial officer

Chief operating officer

Nandan Oza2015

20202025

Chief executive officerSteven Lo Oct 23, 2019 to Jun 7, 2022¹¹
Chief executive officerKonstantinos Alataris Feb 4, 2016 to Mar 22, 2017¹²
Chief executive officerVikram Lamba Jan 26, 2015 to Jan 26, 2015¹³
PresidentVikram Lamba Jan 26, 2015 to Jan 26, 2015¹³
PresidentKonstantinos Alataris Oct 1, 2015 to Mar 22, 2017¹⁴
Chief financial officerChristine Matthews May 5, 2020 to Jun 7, 2022¹⁵
Chief financial officerGregory David Kitchener Oct 16, 2018 to Jun 19, 2019¹⁶
Chief financial officerGeorgia Erbez Jun 24, 2016 to May 25, 2017¹⁷
Chief financial officerWinnie Wing-Kei Tso Jan 26, 2015 to Apr 12, 2017¹⁸
Chief operating officerNandan Oza Jan 26, 2015 to Jan 26, 2015¹⁹

Board members and other officers (21)

OfficerChristine Matthews Feb 3, 2020 to Feb 3, 2020²⁰
VP, Clinical Dev & Med AffairsDonald J. Kellerman Jun 24, 2016 to Apr 1, 2022²¹
VP, Engineering & OperationsEric Scharin Jun 24, 2016 to Jul 1, 2016²²
VP, Reg Affairs & QAHayley Lewis Jun 24, 2016 to Jun 7, 2021²³
VP, Strategy & Corp. Develop.Alexander Ramsay Strange Jan 26, 2015 to Jan 26, 2015²⁴
Chief Scientific OfficerPeter E. Daddona Jan 26, 2015 to Jan 26, 2015²⁵
Sr. Vice President, OperationsLaxmi Peri May 7, 2015 to Dec 16, 2015²⁶
Board memberKathy M. McGee May 25, 2021 to May 25, 2021²⁷
Board memberElaine Yang Dec 9, 2021 to Dec 9, 2021²⁸
Board memberLinda S. Grais Jan 16, 2019 to Jun 14, 2021²⁹
Board memberSteven Lo Oct 23, 2019 to Jun 7, 2022¹¹
Board memberSteve Elms May 21, 2018 to Jun 14, 2021³⁰
Board memberKenneth Greathouse Oct 5, 2017 to Nov 24, 2021³¹
Board memberKonstantinos Alataris Feb 4, 2016 to Mar 22, 2017¹²
Board memberBruce D. Steel Jan 26, 2015 to Jan 26, 2015³²
Board memberKleanthis G. Xanthopoulos Jan 26, 2015 to Jun 14, 2021³³
Board memberM. James Barrett Jan 26, 2015 to Feb 2, 2015³⁴
Board memberPeter E. Daddona Jan 26, 2015 to Jan 26, 2015²⁵
Board memberTroy Edward Wilson Jan 26, 2015 to Jul 18, 2019³⁵
Board memberVikram Lamba Jan 26, 2015 to Jan 26, 2015¹³
Board memberJoseph P. Hagan May 27, 2015 to Jun 14, 2021³⁶

Former names

ZP Holdings IncSep 20, 2013 to May 13, 2014²

Timeline

Oct 23, 2019New chief executive Steven Lo becomes CEO¹¹
Feb 4, 2016New chief executive Konstantinos Alataris becomes CEO¹²
Jan 26, 2015New chief executive Vikram Lamba becomes CEO¹³
Jan 26, 2012Founded Zosano Pharma Corp is founded³⁷

Filings

42 filings to the SEC since October 2021: 2 annual reports, 2 quarterly reports, 20 major events, 11 insider forms, 1 large holders, 6 other. The latest 20:

Jun 7, 20224 FORM 4 SUBMISSION EDGAR
Jun 7, 20224 FORM 4 SUBMISSION EDGAR
Jun 3, 20228-K EDGAR
Jun 2, 20228-K EDGAR
May 18, 2022SC 13G SCHEDULE 13G EDGAR
May 18, 20228-K EDGAR
May 13, 202210-Q EDGAR
May 13, 20228-K EDGAR
May 5, 20228-K EDGAR
Apr 29, 202210-K/A EDGAR
Apr 29, 20228-K EDGAR
Apr 11, 20228-K EDGAR
Apr 1, 20224 EDGAR
Apr 1, 20224 EDGAR
Apr 1, 20224 EDGAR
Apr 1, 2022S-8 EDGAR
Mar 17, 202210-K EDGAR
Mar 17, 20228-K EDGAR
Feb 25, 2022DEF 14A EDGAR
Feb 18, 20228-K EDGAR

The 42 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 1 such filings since October 2021:

May 18, 2022SC 13G

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZosano Pharma Corp filings on SEC EDGAR
2
SEC EDGARZosano Pharma Corp filings on SEC EDGAR
3
SEC EDGARZosano Pharma Corp 10-K for fiscal 2021
4
SEC EDGARZosano Pharma Corp 10-K for fiscal 2015
5
SEC EDGARZosano Pharma Corp 10-K for fiscal 2016
6
SEC EDGARZosano Pharma Corp 10-K for fiscal 2017
7
SEC EDGARZosano Pharma Corp 10-K for fiscal 2018
8
SEC EDGARZosano Pharma Corp 10-K for fiscal 2019
9
SEC EDGARZosano Pharma Corp 10-Q for fiscal 2022
10
SEC EDGARZosano Pharma Corp 10-K for fiscal 2015
11
SEC EDGARSteven Lo, Chief executive officer
12
SEC EDGARKonstantinos Alataris, Chief executive officer
13
SEC EDGARVikram Lamba, Chief executive officer
14
SEC EDGARKonstantinos Alataris, President
15
SEC EDGARChristine Matthews, Chief financial officer
16
SEC EDGARGregory David Kitchener, Chief financial officer
17
SEC EDGARGeorgia Erbez, Chief financial officer
18
SEC EDGARWinnie Wing-Kei Tso, Chief financial officer
19
SEC EDGARNandan Oza, Chief operating officer
20
SEC EDGARChristine Matthews, Officer
21
SEC EDGARDonald J. Kellerman, VP, Clinical Dev & Med Affairs
22
SEC EDGAREric Scharin, VP, Engineering & Operations
23
SEC EDGARHayley Lewis, VP, Reg Affairs & QA
24
SEC EDGARAlexander Ramsay Strange, VP, Strategy & Corp. Develop.
25
SEC EDGARPeter E. Daddona, Chief Scientific Officer
26
SEC EDGARLaxmi Peri, Sr. Vice President, Operations
27
SEC EDGARKathy M. McGee, Board member
28
SEC EDGARElaine Yang, Board member
29
SEC EDGARLinda S. Grais, Board member
30
SEC EDGARSteve Elms, Board member
31
SEC EDGARKenneth Greathouse, Board member
32
SEC EDGARBruce D. Steel, Board member
33
SEC EDGARKleanthis G. Xanthopoulos, Board member
34
SEC EDGARM. James Barrett, Board member
35
SEC EDGARTroy Edward Wilson, Board member
36
SEC EDGARJoseph P. Hagan, Board member
37
gleifZosano Pharma Corp is founded